home / stock / rmd / rmd news


RMD News and Press, ResMed Inc. From 09/17/23

Stock Information

Company Name: ResMed Inc.
Stock Symbol: RMD
Market: NYSE
Website: resmed.com

Menu

RMD RMD Quote RMD Short RMD News RMD Articles RMD Message Board
Get RMD Alerts

News, Short Squeeze, Breakout and More Instantly...

RMD - Dividend Champion, Contender, And Challenger Highlights: Week Of September 17

2023-09-17 07:33:42 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

RMD - Here's The Price I'll Buy ResMed Stock

2023-09-17 07:31:40 ET Summary ResMed stock's high valuation from 4 years ago is finally being reflected in the current stock price. The historical earnings pattern of ResMed has been stable and consistent, making it a rare achievement. Using a 10-year earnings CAGR estimate, ...

RMD - 3 Top Growth Stock Picks Trading at a Massive Bargain

2023-09-13 08:27:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the market rallying hard lately, it’s easy to think every stock is participating in the gains. But look a little closer, and you’ll see the rally has been very narrow. Most o...

RMD - ResMed - Trading Opportunity Now

2023-09-12 15:27:28 ET Summary ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter the market has marked the stock down due to c...

RMD - ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity

2023-09-12 11:52:41 ET Summary RMD is a buy as I expect that the market will re-evaluate the stock and return it to its historical average. Sales for ResMed in 4Q23 increased by 23% YoY, driven by device sales and unexpected growth in mask sales. Gross margin pressures persist...

RMD - Why DexCom May Be Up To 40% Undervalued

2023-09-12 08:00:00 ET Summary DexCom is a leading healthcare stock that has seen significant growth, with shares returning close to 1,400% in the past decade. DXCM stock has faced resistance and is currently 37% below its all-time high, partly due to competition from weight loss ...

RMD - Charting The Moat Index's Long-Term Track Record

2023-09-09 08:15:00 ET Summary Morningstar's moat indexes have a history of outperforming the S&P 500 over long holding periods. The Moat Index underperformed the S&P 500 by 2% in August, but remains ahead by 500 basis points for the year. Smaller-cap companies had mor...

RMD - ResMed Announces Participation in Upcoming Conferences

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief financial officer, will participate in a fireside chat at the M...

RMD - 3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy

2023-09-01 06:21:00 ET Every quarter, investors get excited for companies to report earnings. Some want the updated numbers that management teams share. Others are more curious to hear about plans and projections. Executives' comments are well-scripted and aren't usually controversial enoug...

RMD - Insulet spikes as CEO buys over $1M shares

2023-08-30 10:11:37 ET More on Insulet Insulet: Losing More Weight Insulet: High Growth Not Translating To Economic Value For Shareholders (Rating Downgrade) Insulet Corporation ( PODD ) Q2 2023 Earnings Call Transcript Insulet Corporation: Margins Are On...

Previous 10 Next 10